RIO DE JANEIRO, BRAZIL – (Opinion) All but one of the so-called BRICS countries – Brazil, Russia, India, China, but not South Africa – are today engaged in a “soft power” exercise that is called “vaccine diplomacy”: sometimes their interests are mutual, sometimes at cross purposes.
China, where the coronavirus causing Covid-19 first arose, has been trying to apologize by becoming the leader in promoting vaccines to prevent the disease. Chinese pharmaceutical giants Sinopharm and Sinovac have rolled out billions of doses of the finished product and of the active pharmaceutical ingredient (API) needed for their manufacture.
Detail: Coronavac, the vaccine . . .